Besides, we have previously demonstrated that PTPRO inhibited ERBB2-driven breast cancer through dephosphorylation leading to dual effects of ERBB2 signaling suppression and endosomal internalization of ERBB2 (Dong et al., 2017a). Here, PTPRO is linked to breast carcinoma.